Immunomagnetic separation of infiltrating T lymphocytes from brain tumors
- 1 August 1989
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 71 (2) , 218-223
- https://doi.org/10.3171/jns.1989.71.2.0218
Abstract
Tumor-infiltrating lymphocytes (TIL's) were isolated from human glioma biopsy specimens by immunomagnetic separation using T cell-specific monoclonal antibodies coupled to paramagnetic beads, and were expanded in culture with feeder cells and interleukin-2 (IL-2). The infiltrating cells from five of seven patients proliferated in culture. When tested after 2 to 3 weeks of culture, virtually all of the cells stained with antibodies against the CD2 and CD3 antigens. Most cells also expressed human leukocyte antigen class II molecules, while varying percentages of cells stained with antibodies against the IL-2 receptor and the CD4 and CD8 antigens. The cytotoxicity of the cultured TIL's against autologous and allogeneic glioma cells and the K562 and Daudi cell lines was measured and compared with that of lymphokine-activated killer (LAK) cells from the same patients. None of the TIL's showed significant cytotoxicity against these targets, whereas LAK cells lysed all of the targets.Keywords
This publication has 24 references indexed in Scilit:
- Positive selection of activated T cells of the T8 (CD8) sub-type by immunomagnetic separationTissue Antigens, 2008
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- Interleukin‐2‐stimulated natural killer activity against malignant and benign endometriumInternational Journal of Cancer, 1987
- Activation of Resting, Pure CD4+, and CD8+ Cells via CD3.Scandinavian Journal of Immunology, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Evidence for three types of human cytotoxic lymphocyteImmunology Today, 1986
- Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated LymphocytesAnnual Review of Immunology, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- cis-platinum as adjunctive to surgery in early stage ovarian carcinoma: Effects on lymphoid cell subpopulationsGynecologic Oncology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985